Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

Diabetes Drug Seeks Approval for Weight Loss

The drug works by suppressing appetite, making it easier for people to stick to a healthy diet and exercise plan.

Screenshot 2023 04 28 At 3 35 50 Pm
Eli Lilly

According to a recent ABC News article, Eli Lilly’s popular Type 2 diabetes drug Mounjaro could be approved for weight loss by the end of 2023. The drug, marketed under the brand name Wegovy, was originally approved as a diabetes medication but has been found to promote weight loss in clinical trials. It is administered via injection once a week and is designed to help people with obesity lose weight and improve their overall health.

FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?
Break out of the ordinary: see what’s new in life sciences packaging
<strong>At PACK EXPO Las Vegas, you’ll see machinery in action and new tech from 2,300 suppliers, collaborate with experts and explore transformative solutions. Join us in September to experience a breakthrough for life sciences products.</strong>
REGISTER NOW & SAVE!
Break out of the ordinary: see what’s new in life sciences packaging